Transfusion medicine and spongiform encephalopathy

被引：18

作者：

Brown, P ^{[1
]}

机构：

[1] NIH, Bethesda, MD 20892 USA

来源：

TRANSFUSION | 2001年 / 41卷 / 04期

关键词：

D O I：

10.1046/j.1537-2995.2001.41040433.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：433 / 436

页数：4

共 27 条

[1] Distribution of cell-associated prion protein in normal adult blood determined by flow cytometry [J].

Barclay, GR ;

Hope, J ;

Birkett, CR ;

Turner, ML .

BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (04) :804-814

[2] Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: Background, evolution, and current concerns [J].

Brown, P ;

Will, RG ;

Bradley, R ;

Asher, DM ;

Detwiler, L .

EMERGING INFECTIOUS DISEASES, 2001, 7 (01) :6-16

[3] Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease [J].

Brown, P ;

Cervenáková, L ;

Diringer, H .

JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2001, 137 (01) :5-13

[4] Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans [J].

Brown, P ;

Cervenáková, L ;

McShane, LM ;

Barber, P ;

Rubenstein, R ;

Drohan, WN .

TRANSFUSION, 1999, 39 (11-12) :1169-1178

[5] The pathogenesis of transmissible spongiform encephalopathy: routes to the brain and the erection of therapeutic barricades [J].

Brown, P .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2001, 58 (02) :259-265

[6] CREUTZFELDT-JAKOB DISEASE AND BLOOD-TRANSFUSION [J].

ESMONDE, TFG ;

WILL, RG ;

SLATTERY, JM ;

KNIGHT, R ;

HARRIESJONES, R ;

DESILVA, R ;

MATTHEWS, WB .

LANCET, 1993, 341 (8839) :205-207

[7] Surveillance for Creutzfeldt-Jakob disease among persons with hemophilia [J].

Evatt, B ;

Austin, H ;

Barnhart, E ;

Schonberger, L ;

Sharer, L ;

Jones, R ;

DeArmond, S .

TRANSFUSION, 1998, 38 (09) :817-820

[8] Binding of disease-associated prion protein to plasminogen [J].

Fischer, MB ;

Roeckl, C ;

Parizek, P ;

Schwarz, HP ;

Aguzzi, A .

NATURE, 2000, 408 (6811) :479-483

[9] Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products [J].

Foster, PR ;

Welch, AG ;

McLean, C ;

Griffin, BD ;

Hardy, JC ;

Bartley, A ;

MacDonald, S ;

Bailey, AC .

VOX SANGUINIS, 2000, 78 (02) :86-95

[10]

Foster PR, 1999, TRANSFUSION MED, V9, P3

← 1 2 3 →